Cytokinetics Inc. and Amgen's newest drug had very promising results during its Phase 2 clinical trial. This gives the researchers hope that the making of a drug that can improve cardiac function after heart failure is well on its way.
Cytokinetics, Amgen Heart Failure Drug Shows Promise In Clinical Study
Tech Times - 9 Nov 2015 04:49
Cytokinetics Inc. and Amgen's newest drug had very promising results during its Phase 2 clinical trial. This gives the researchers hope that the making of a drug that can improve cardiac function after heart failure is well on its way.
Share this Article
Recommended